The next SPAC is here, com­ing from a phar­ma e-com­merce CEO, as a Flori­da biotech prices at the low end

The newest health­care blank-check com­pa­ny has ar­rived, com­ing from the CEO of a com­pa­ny that is at­tempt­ing to shake up the dig­i­tal phar­ma­ceu­ti­cal space.

The SPAC known as Aes­ther Health­care Ac­qui­si­tion filed for its ini­tial of­fer­ing late Mon­day, putting down $100 mil­lion as its raise es­ti­mate. Led by Suren Aj­jara­pu, chief ex­ec­u­tive of on­line drug mar­ket­place TRx­ADE Health, the SPAC is tar­get­ing phar­ma­ceu­ti­cals, medtech and health­care IT.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER